Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Divozilimab (anti-CD20)
Price: Check
Purity: 95.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

2254061-60-2

2254061-60-2 structure

2254061-60-2 structure

Name: Divozilimab
Chemical Name: Divozilimab
CAS Number: 2254061-60-2
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Inflammation/Immunology
Create Date: 2023-02-18 18:17:33
Modify Date: 2025-08-25 07:49:29
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research[1].

Name	Divozilimab

Description	Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research[1].
Related Catalog	Research Areas >> Inflammation/Immunology
References	[1]. O V Boyko, et al. Results of a phase 1 clinical study of anti-CD20 monoclonal antibody (BCD-132): pharmacokinetics, pharmacodynamics and safety. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):87-95.

No Any Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.